Calcium metabolism and vitamin D in the extreme longevity

doi:10.1016/j.exger.2007.06.013

Journal List > NIHPA Author Manuscripts

Exp Gerontol. Author manuscript; available in PMC 2009 February 20.

Published in final edited form as:

Exp Gerontol. 2008 February; 43(2): 79–87.

Published online 2007 July 4. doi: 10.1016/j.exger.2007.06.013

PMCID: PMC2645636

NIHMSID: NIHMS45521

Calcium metabolism and vitamin D in the extreme longevity

Giovanni Passeri,^a^* Rosanna Vescovini,^a Paolo Sansoni,^a Carlo Galli,^a Claudio Franceschi,^b^c Mario Passeri,^a and The Italian Multicentric Study on Centenarians (IMUSCE)¹

^a Dipartimento di Medicina Interna e Scienze Biomediche, Università di Parma, Via Gramsci 14, I-43100 Parma, Italy

^b Dipartimento di Patologia Sperimentale, Università di Bologna, Via S. Giacomo 12, I-40100 Bologna, Italy

^c Dipartimento di Ricerca Gerontologica, INRCA, Via Birarelli 8, I-60121 Ancona, Italy

^* Corresponding author. Tel.: +39 0521 033321; fax: +39 0521 033271. E-mail address: giovanni.passeri/at/unipr.it (G. Passeri)

¹For IMUSCE see Appendix 1.

The publisher's final edited version of this article is available at Exp Gerontol

See other articles in PMC that cite the published article.

Abstract

Skeletal remodelling is a continuous process during life and is still active also in extreme senescence. In the elderly, bone resorption often prevails over bone formation, causing bone loss and fragility. Elderly subjects are exposed to the risk of fractures, and loss of self-sufficiency, if considering that the proximal femur is the most frequently involved site. Bone remodelling can maintain circulating calcium within physiological ranges, at the expense of a substantial loss of this ion from the skeleton, particularly during senescence. Calcium metabolism is regulated at cellular/molecular level by a network of cytokines, growth factors, systemic hormones that act on bone in paracrine/autocrine/systemic fashion. Among the molecules involved in bone metabolism, parathyroid hormone (PTH) and vitamin D present some peculiar aspects during senescence. The osteometabolic features in a consistent group of centenarians have been evaluated. It results that a severe hypovitaminosis D was present in 99 out of 104 centenarians (25-OH vitamin D below 5 nmol/L), and that it plays an important role as a factor inducing a vicious circle involving hypocalcemia, secondary hyperparathyroidism, together with biochemical features indicating a consistent bone loss. Serum C-terminal cross-linking telopeptide, a specific marker of bone resorption was elevated in 92% of these subjects. Moreover, it has been found that several femoral fractures had occurred after 90 years of age. These data offer a rational for the possible prevention of elevated bone turnover, bone loss and consequently the reduction of osteoporotic fractures and fractures-induced disability, in the oldest olds, through the simple supplementation with calcium and vitamin D.

Keywords: Vitamin D, Calcium metabolism, Extreme longevity, Bone fractures, Osteoporosis, Self-sufficiency

1. Introduction

Considering the fast increase of life expectancy worldwide and in the developing countries in particular, the maintenance of self-sufficiency is of extreme importance in the oldest olds. Among those able to reach the extreme limits of life, centenarians represent an example of successful aging, due probably to their genotypes and to peculiar neuro-immuno-endocrine mechanisms (; ; ; Mari et al., 1996; De Benedictis et al., 1997; ; ; ).

It is true that prevention of bone fragility fractures is of pivotal importance at all ages, but this is even more important in the oldest olds, since a fracture, especially of the hip, often means the permanent loss of walking ability, and of self-sufficiency (Passeri, 1991; ; ). Elderly subjects are at risk of fractures for several reasons: falls are of primary importance, but a relevant role is also played by loss of bone mass with subsequent reduction of bone strength (osteoporosis). Insufficient dietary intake of calcium, low physical activity, systemic diseases and medical treatments affecting bone, hormonal status, and finally, low circulating levels of vitamin D are all co-morbidity factors (; Rosen and Kiel, 1999; Martini and Passeri, 2000; ; ). The skeletal remodelling, consisting of a continuous process of bone resorption of the pre-existing bone followed by bone formation, remains active even after 80 years of age. However, it is evident a disequilibrium of these two processes, with a prevalence of bone resorption, especially in the elderly (Passeri, 1991; Marcus et al., 1995; Martini and Passeri, 2000; ). It has been demonstrated, above the age of 60 years, a clear prevalence of bone resorption, while bone formation is of varying extent, even if several metabolic parameters (e.g., serum osteocalcin) are also increased (). Some changes characterizing aging at the cellular level, are due to a reduced numbers of fully functional cells, accompanied by impaired matrix production, cellular composition, and bone micro-environments, and altered responses to the environment ().

Nevertheless, bone remodelling is closely correlated with calcium exchange, and is strongly influenced by the actions of vitamin D (). As it is well known, calcium is an ion of fundamental importance for all living systems, and it has a great number of functions at both intra- and extra-cellular levels (e.g., blood coagulation, function of adhesive molecules, muscular contraction, second messenger functions in the cells, etc.) (Bringhurst, 1995). In bone, calcium is of basic importance for skeletal physical resistance and as a deposit from which the organism can mobilize calcium when needed. The extra-cellular concentration of Ca²⁺ ions is in the order of 10⁻³ M, while in the cellular cytoplasm is only around 10⁻⁶ M. Free cytoplasmatic Ca²⁺ may quickly and largely changes its concentration (up to 100 times), as a consequence of the binding of primary extra cellular messengers to the respective receptors on the membrane of the target cells. Among the fractions of the circulating calcium (bound to proteins: about 40%; complexed mainly with citrate and phosphate ions: about 10%; and the rest is ionized) (Bringhurst, 1995), the ionized fraction is the most important from a physiological point of view and it is maintained in a very narrow range by the combined effects of different hormones, in particular PTH, 1,25(OH)₂D₃ and calcitonin (Parfitt, 1993).

These are the main factors able to control the global balance of calcium in the body, by regulating the bi-directional calcium fluxes between the gastrointestinal system, kidneys, and bones, toward the extra cellular calcium pool (Bringhurst, 1995). Nevertheless, other hormonal factors, whose secretion is not directly regulated by calcium circulating levels, have a considerably importance in calcium exchanges and, eventually, for bone health: sexual steroids, thyroid hormones, glycocorticoids and growth hormone (GH) are the most important (Marcus et al., 1995; ).

2. Calcium metabolism

Intestinal calcium absorption is determined by the amount of calcium present in the food and by the absorptive capabilities of the intestine itself, at the level of duodenum and upper part of the jejunum. When the amount of calcium introduced with diet is less than 200 mg/day, the net intestinal absorption is practically zero, since approximately the same quantity is daily secreted into gastrointestinal lumen, and lost with the feces. When dietary calcium is above 200 mg/day, the absorbed amount will vary between 15% and 40%, through both passively and actively regulated transport mechanisms. The latter are mostly regulated by the circulating levels of 1,25(OH)₂D₃ ().

The most important regulatory site of calcium excretion is the kidney. Serum Ca²⁺ is filtered at the glomerular level (about 10 g/day), and then is almost completely reabsorbed (about 9.85 g/day), and only about 1–3% of filtered calcium is excreted with the urine. This mechanism is regulated by PTH (Suki and Rouse, 1996). Calcium is bound in the bone to the connective tissue fibres, (the osteoid protein matrix), and is released from this site as the effect of bone remodelling. In a healthy adult there is equilibrium between the bi-directional calcium fluxes from and to the bone. This equilibrium is unbalanced either towards bone resorption when circulating ionized calcium levels are low, or towards deposition of calcium in the bone. Therefore, this means that the skeleton is the natural, dynamic reserve of calcium for the organism (Passeri, 1991; Marcus et al., 1995).

3. The role of the vitamin D

The action of the vitamin D, especially the active form 1,25(OH)₂D₃, is of fundamental importance in most of the bone metabolic equilibrium processes. Vitamin D is a secosteroid synthesized in the skin starting from 7-dehydro-cholesterol: the UV light catalyzes this reaction, or it can also be introduced in the body orally or parenterally (; Holick, 1995). Several factors may interfere with the skin-production of vitamin D: an increase in the melanin in the skin, insufficient sun exposure and even the angle of incidence of sun light on the skin surface. This last factor may indeed is important at latitudes far from the equator: especially during winter, sunlight has been demonstrated to induce a very low cutaneous production of vitamin D (Holick, 1995).

Vitamin D₃ may be absorbed from the intestine, by consuming food rich in the compound such as fat fishes (salmon and mackerel), oil of fat fishes, i.e. cod-liver oil, or yolk. Vitamin D₂, has a metabolic behaviour identical with vitamin D₃, is a plant derivative. In many countries, due to an insufficient dietary intake, vitamin D is added to milk, cereals, bread and dairy products. The daily requirement of vitamin D varies according to the age and also to particular conditions such as gestation or lactation or elderly. For an adult subject, in total absence of solar exposition, doses of 600–800 IU per day are needed (Marcus et al., 1995). Vitamin D from the diet, due to its lipo-solubility, will be incorporated in chylomicrons and absorbed through the lymphatic system. Subsequently, it is bound to a vector protein, independently from its origin, and is transported to the liver, where the initial phase of activation takes place, through the formation of 25-OH-cholecalciferol (25-OH vitamin D, or calcifediol). Then, this metabolite enters the circulation, where it is transported by a globulin. 25-OH vitamin D has a half-life of 2–3 weeks, and its serum levels may be utilized as an indicator of the vitamin D status of the subjects, since it reflects the cumulative effects of the vitamin intake and production by the sunlight (; , 1995).

25-OH vitamin D is transported to the kidney, where it undergoes a second hydroxylation resulting in the final active metabolite 1,25(OH)₂ vitamin D₃ or calcitriol, that is 500–1000 folds more active than its precursor 25-OH vitamin D. Calcitriol is not often considered as marker of vitamin D status, since is light sensitive, easily degradated, and the method for evaluation is rather complicated as compared to measuring 25-OH vitamin D.

The mechanism of action of calcitriol is similar to other steroid hormones, on different types of target tissues (most of tissues of the organism), that have a specific receptor for the vitamin D (VDR) with an affinity 1000 times higher for the 1,25(OH)₂D₃ than for the other mono-hydroxylated metabolites of this vitamin ().

1,25(OH)₂D₃ regulates the synthesis of calbindine, a protein that binds calcium and has also a “non genomic” action, based on the interaction of 1,25(OH)₂D₃ with a cell membrane protein different from the VDR, causing the opening of the calcium-channels. It is assumed that these mechanisms are responsible for at least one-third of the total calcium absorbed daily ().

At the bone level, calcitriol is able to stimulate normal bone growth, and it is of fundamental importance in the mineralization processes. Probably, it mainly increases the intestinal absorbance of calcium and phosphates, allowing these components for the deposition of crystals onto the collagen fibres of the osteoid proteic matrix. There are also receptors for 1,25(OH)₂D₃ on osteoblastic cells, able to stimulate their activity ().

4. Vitamin D insufficiency

Hypovitaminosis D always causes a reduction of calcium intestinal absorption that induces a negative calcium balance. Hypocalcemia due to insufficient calcium absorption, induces an increment of PTH with also an increase of the synthesis of 1,25(OH)₂D₃. This induces resorption of calcium from bone, in order to maintain serum calcium within normal levels.

Obviously, the grade and duration of the vitamin D insufficiency are important. In the past, the lower limit for 25-OH vitamin D was considered 25–37.5 nmol/L, more recently most laboratory reference ranges have extend the lower limit up to 100 nmol/L (). Serum 25-OH vitamin D concentration below 20 nmol/L is associated with clinical osteomalacia in adults and elderly people (), with defects of mineralization of the newly formed osteoid matrix. The consequence of a moderate insufficiency defined as a serum level of 25-OHD between 37.5 and 75 nmol/L, can be considered as facilitating factor for the development of osteoporosis, while the range between 20 and 40 nmol/L have been called vitamin D insufficiency, in recognition of its inadequacy for optimal functioning of vitamin D and calcium metabolism (, ).

An increased fractional calcium absorption has been documented with increasing levels of 25-OH vitamin D up to 80 nmol/L, as well as an inverse association between low serum concentration of 25-OH vitamin D and high level of PTH has been reported (). Recently, it has been shown that calcium malabsorption and increased fracture risk are present at 25-OH vitamin D concentrations below 80 nmol/L (). Especially in the elderly, low bone mass in the presence of vitamin D insufficiency have been defined as osteoporo-malacia (Ringe, 1998).

5. Bone metabolism during aging

Compared to the considerable amount of knowledge regarding bone metabolism, calcium exchange and vitamin D metabolism in adults and children, little is known regarding the situation in extreme longevity. It has been demonstrated that aging is accompanied by low dietary calcium intake, due to reduced intestinal absorption, altered renal re-absorption, and increment of both bone remodelling and intracellular calcium. Vitamin D levels tend to decrease, and circulating PTH levels are increased. All these events favour a negative calcium balance and a progressive loss of calcium from the skeleton in elderly subjects. This trend influences bone, the main site of calcium deposition. Bone mass is decreases and consequently, skeletal fragility increases with a significantly higher risk of fractures, especially at the hip, that may lead to a partial or total loss of self-sufficiency (Passeri, 1991; ).

The daily calcium requirement, in elderly subjects, has been estimated around 1500 mg/day, and very often this goal is not achieved. It is well known that daily calcium intake in the elderly is often below 600–800 mg/day ().

It has also to be considered the progressive decline of efficiency in the intestinal calcium absorption, starting after the age of 60–65 years. This trend is due to the decreased production of gastric acid, leading to a lower amount of intra-luminal ionized calcium, the changes of duodenal mucosa, and the impairment in vitamin D levels (Marcus et al., 1995).

The decreased absorption of calcium and the age-dependent decline in serum proteins, could result in a trend to a lower level of serum calcium. This is, however, compensated by the increased circulating level of PTH (; ). In this regard, have clearly demonstrated that elderly women with secondary hyperparathyroidism started to return toward normal values (PTH levels similar to those of the younger adults) after 3 years treatment with a calcium-rich diet. This means that the aging process is associated with deep changes in calcium homeostasis at both intra- and extra-cellular levels. From a quantitative point of view, the most relevant aspect is an accelerated bone remodelling, mainly in resorption, resulting in a loss of calcium from bone. In elderly people, intestinal and urinary losses of calcium are not reduced, in spite of the decreased calcium intake and increased PTH secretion, therefore is not possible to maintain the skeletal calcium content ().

The theory of “shift of calcium” during aging has been proposed, for the first time, approximately 50 years ago. It was suggested that the progressive loss of bone calcium and its deposition in the soft tissues could be the leading cause for the increased presence of osteoporosis, hypertension, and arteriosclerosis in the elderly subjects (). This old and over simplified idea should be kept, anyway, into some consideration.

As a matter of fact, a global increase in bone remodelling has been documented in elderly subjects with the prevalence of resorption over formation of bone tissue, resulting in weakening of bone mass, and progressive loss of total calcium content of the body (). In contrast to the trend of progressive loss of bone mass, increased turn-over, and decreased total calcium content of the body, observed during aging, a contemporary and gradual accumulation of calcium deposited in a non-exchangeable form has been demonstrated: in vessel walls, in extra bone calcifications and also in different intracellular compartments (Fujita, 1986). The atherosclerosis is, at least in part, correlated with an altered calcium homeostasis in endothelial cells of vascular system. The increased flux of calcium in towards cells is associated, and perhaps also induced, by the presence of plasma lipoproteins like LDL, with a consequent production of growth factors and cytokines. This induces the entrance of lymphocytes and macrophages into vessel walls, as well as, the proliferation of smooth muscle cells, inducing the formation of the atheromasic lesions ().

In the past few years, it has been demonstrated that a protein of the Tumor Necrosis Factor superfamily, receptor activator of nuclear factor kB ligand (RANK-L), its receptor (RANK, receptor activator of nuclear factor kB) and the decoy receptor osteoprotegerin (OPG), are key regulators of bone resorption in vitro and in vivo. RANK-L is expressed by osteoblasts, bone marrow stromal cells and activated T lymphocytes cells. RANK is present as transmembrane receptor on cells of osteoclastic lineage, and OPG is produced by osteoblasts (; ). Studies on OPG/RANK/RANK-L network has provided new insights regarding bone remodelling as well as vascular diseases (; ; ; ). PTH and vitamin D are involved in OPG/RANK-L expression and regulation (Suda et al., 2003), and it has been shown that OPG is increasing after 70 years of age and in centenarians, as a possible, although insufficient mechanism able to limit bone loss (; Passeri et al., 2005), or as marker of inflammation and cardiovascular risk ().

Circulating PTH is often increased in the elderly, and induces the entrance of Ca²⁺ from the extra-cellular to the intra-cellular compartments, i.e., acting as an ionophore. With advancing age, a gradual vitamin D deficiency becomes evident (; ; ; ). This is due, to a reduction of the concentration of 7-dehydrocholesterol in the epidermis, typical during aging, and to a consequent decrease of synthesis under UV irradiation (, 1995). On the other hand, a decreased exposition to UV light is frequent in the elderly people, especially when they are unable to exit from their residences, or disable and recovered in protected care-giving facilities. In addition, a low nutritional intake of vitamin D is present. These conditions are particularly frequent: 60–80% of the institutionalized elderly population and about 50% of the non-institutionalized women present a primary deficit of vitamin D, especially during winter season (Lorè et al., 1986; Rossini et al., 1990; ; ; ; ).

The reduced efficiency of the renal 1α-hydroxylase present during aging, and the progressive decline of renal functions, may explain the low serum levels of active 1,25(OH)₂D₃. This situation is further influenced by a decreased cellular response to PTH, and in women, by the hypo-estrogenism following menopause (; ; ; Nuti and Martini, 1994; ). Therefore, the intestinal calcium absorption is reduced to an extent similar to malabsorptive syndromes (i.e. Celiac disease and Chron disease), where hypovitaminosis D is also present ().

It seems clear that elderly subjects often present 1,25(OH)₂D₃ deficiency, that reduce calcium absorption, and this is responsible for the secondary hyperparathyroidism that eventually is leading to an increased bone loss.

A mechanism able to explain the reduced biological activity of 1,25(OH)₂D₃ in the elderly has also been suggested, consisting in an increased resistance of the target organs to the action of vitamin D (). Such a resistance could be explained by a reduced number of intestinal VDRs (; ; ), associated with estrogens deficiency, as it was shown after ovariectomy, or by some post-receptorial defects (Parfitt, 1993; ).

Considered all the above, it can be considered that hypovitaminosis D has multi-factorial origin in elderly. This deficiency may play a role not only in Osteomalacia, characterized by defective mineralization of bone, but also in Osteoporosis, the most prevalent bone disease.

6. Bone metabolism in centenarians

Some of the peculiarities of aging regarding calcium metabolism and vitamin D status have been confirmed in extreme senescence.

To this aim, we studied 104 subjects (90 females and 14 males) ranging between 98 and 105 years of age. They were residents in the areas of Parma and Mantova (Italy, 44° parallel north), and were living either at home or in nursing facilities. A detailed history, and general physical examinations were performed, in order to document whether any acute disease was present. Fifty-eight of these centenarians presented signs of dementia, as revealed by using the mini-mental state examination (MMSE) (; Guralnik et al., 1994). General hematochemical parameters, as well as specific ones related to the bone turnover, were also studied.

We found that half of them (50/104) were able to walk, 19 without any help. Nine of these 19 centenarians demonstrated stability, when this function was specifically considered, using performance-based measures as the EPESE short battery. This battery integrates the following tests: rising from a chair, timed walk over a 4.5 m course, and capacity to maintain balance in progressively more challenging standing position (balance tests) (Guralnik et al., 1994).

The medical history revealed that the subjects sustained 55 falls during the year preceding the study. It was also established that 40 centenarians sustained at least one fracture mostly due to minimal traumas or spontaneously. One-third of them was able to walk with sticks or other supporting aids, and more then 60% of this group have had at least one bone fragility fracture, while 12 of the 19 patients able to walk without help, have never suffered any fractures.

Bone densitometry by DXA analysis was not performed because of the difficulties of take most of these frail subjects to the Centre for Metabolic Bone Diseases of the Department of Internal Medicine and Biomedical Sciences of the University of Parma.

Therefore, we studied several characteristics of the bone tissue by ultra-sonography () using two portable instruments. The Osteosonographer DBM Sonic (IGEA, Carpi, Italy) was used to study 60 centenarians, evaluating the amplitude-dependent speed of sound (AD-SoS) on the proximal phalanges of the non-dominant hand, a bone site formed for approximately 70% by the cortical bone (). The instrument forwards a calculated value of the risk of bone fractures called ultrasound bone profile index (UBPI). This method has been validated in 10,000 women of various ages including the centenarians (; ; ).

We used also the Sahara Ultrasonographer (Hologic, Walton-MA, USA) for the evaluation of other 28 subjects. This instrument measures both Broadband Ultrasound Attenuation (BUA) and Speed of Sound (SoS). The numeric combination of these two parameters supplies an index called Quantitative Ultrasound Index (QUI), assumed to reflect elasticity and stiffness of bone (). In 16 centenarians ultra-sonographic evaluation was not possible, because of articular retraction of the feet, or due to arthritic deformations of the hands.

In agreement with data from the literature (; ), using both devices very low values were detected (Table 1A), without any significant difference between fractured and non-fractured centenarians (Table 1B).

Table 1

The routine laboratory findings were within the normal limits. It should be underlined that serum creatinine was on average below 1.5 mg/dl, while the value of the calculated creatinine clearance was almost 30 ml/min, using the Cockcroft-Gault formula. The levels of creatinine clearance found in centenarians, although quite low, were not correlated with an increased serum PTH, suggesting that the secondary hyperparathyroidism found, was not due to chronic renal insufficiency. Serum phosphate was in the lowest quartile of the normal range, and calcium was, on average, close to the lower limit of normality, and below 9 mg/dl in 74% of the subjects.

The most significant results, among the specific markers of bone resorption, were serum PTH and 25-OH vitamin D levels (Table 2). The average PTH was twice the normal value, and above the upper limit in 65% of these centenarians. The increased bone resorption was demonstrated by increased levels of serum C-terminal cross-linking telopeptide (S-CTX), above the normal limits in 92% of these subjects, and significantly correlated with PTH (r = 0.37, p < 0.001), in agreement with data from the literature (). Mean bone alkaline phosphatase values were in the upper limit of the normal range, and it was significantly elevated in 32 subjects indicating an increased bone turnover (Table 2). The above listed evidences of an intense bone resorption were particularly evident when the individual markers of turnover (PTH, S-CTX, IL-6) and the serum calcium levels were considered together. In addition, correlations were found between PTH and calcium (r = −0.33, p < 0.001), IL-6 and S-CTX (r = 0.37, p < 0.001), IL-6 and calcium (r = −0.35, p < 0.001), PTH and IL-6 (r = 0.24, p = 0.019). There was no correlation between the creatinine clearance and PTH (r = −0.167, p = not significant) (Passeri et al., 2003).

Table 2

Osteometabolic parameters found in centenarians (104 subjetcs)

There was also a significant correlation between markers of bone turnover and ultrasonographic parameters both at the phalanges and at the calcaneous: PTH and S-CTX versus phalangeal UBPI (r = −0.38, p = 0.032; r = −0.28, p = 0.036, respectively), S-CTX versus calcaneal SoS (r = −0.4, p = 0.05) (Passeri et al., 2003).

An even more evident finding was the severe hypovitaminosis D. The 25-OH vitamin D, measured by RIA (Nichols Institute Diagnostics,CA,USA), was measurable only in 5 subjects, and one of these has had therapeutic supplementation of this vitamin. The values of the other 99 centenarians were below the limit of sensibility of the method used (5 nmol/L).

When considering all these data, they indicate that a considerably large part of the centenarians studied presented an active bone turnover, accompanied by an important loss of bone mass, known from the literature in “younger” elderly people (; ).

It should be emphasized that 100 of the 104 subjects have lived all their lives in an area of Italy where a particular cheese, the “Parmigiano-Reggiano”, the highest in calcium content world wide, is produced, and part of the daily diet. The calcium intake of these subjects was, on average, at least 800 mg/day as revealed by the data obtained using specifically prepared questionnaires. This quantity of dietary calcium is certainly larger than what found in any other regions of Italy among elderly subjects.

Hypovitaminosis D in these centenarians seems to be of great relevance, especially when considering that blood sampling was performed in 60% of them between April and September, when sun exposition is possible. These low levels of 25-OH vitamin D, found in 99 of our 104 centenarians, can explain, on one hand, the high level of serum PTH, and, on the other hand, are certainly not caused by decreased renal functions, as shown by creatinine levels. The vitamin D deficiency and the increased parathyroid function are inducing an active bone turnover, with a tendency for continuous bone loss, present also in the oldest olds. At the same time, these data suggest the need of vitamin D supplementation to the subjects of the oldest old age group. As defined by the Food and Nutrition Board, the adequate intake of vitamin D is between 200 and 600 IU/d (FNB, 1997). 600 IU/d, equivalent to 15 μg/d, is the amount suggested after 70 y of age, as recognition that the contribution of cutaneous sources decreases with age. Several studies have demonstrated that an amount above 1000 IU/d (35 μg/d) are necessary to reach and maintain a circulating concentration of 80 nmol/L, and this can certainly be considered true for the frail centenarians. This supplement may also be beneficial not only for the protection of the skeleton, but also for improving muscle functions that responds positively to the actions of vitamin D (; ; , ).

Appendix A

The Italian Multicenter Study on Centenarians (IMUSCE)

Coordinators: M. Motta, C. Franceschi, L. Motta

List of participants of IMUSCE:

Universities:
University of Bari: A. Capurso, F. Panza, V. Solfrizzi, A. D'Introno, A.M. Colacicco, S. Capurso
University of Bologna: M. Capri, S. Salvioli, S. Valensin
University of Catania: E. Bennati, M. Malaguarnera, D. Maugeri, R. Rapisarda, A. Franzone L. Ferlito
University of Cosenza: G. De Benedictis, M. Berardelli
University of Firenze : G. Masotti, E. Petruzzi, I. Petruzzi, P. Pinzani, D. Monti, F.M. Antonini
University of Foggia: C. Capurso
University of Messina: V. Nicita-Mauro, C. Lo Balbo, A. Mento, C. Nicita-Mauro, G. Maltese, G. Basile
University of Milano: D. Mari, R. Coppola, R. Provenzano
University of Modena: G. Salvioli, M.V. Baldelli, C. Mussi
University of Napoli : M. Varricchio, M. Barbieri, A. Gambardella, G. Paolisso
University of Palermo: C. Caruso, G. Candore, G. Colonna-Romano, D. Lio
University of Parma: P. Sansoni, R. Vescovini, C. Galli, C. Biasini, A. Telera, G. Passeri, M. Passeri
University of Pavia: E. Ferrari, L. Cravello, L. Barili., S.B. Solerte, M. Fioravanti, F. Magri, F. Fagnoni
University of Perugia: U. Senin, P. Mecocci, A. Cherubini
University of Roma “La Sapienza”: V. Marigliano, L. Tafaro, P. Cicconetti, F. Tombesi, M.T. Tombolillo, E. Ettore
University of Siena : S. Forconi, S. Boschi, G.A. Righi, M. Guerrini
University of Trieste: L. Giarelli^†, G. Stanta

Other institutions and specialists:

National Institute on Aging, National Institutes of Health, Baltimore, Bethesda, MD (USA): L. Ferrucci, A. Ble, E.J. Metter, J.M. Guralnik
Istituto Superiore di Sanità, Department of Pharmaca, Roma: R. Pacifici, P. Zuccaro, I. Palmi
Local Sanitary Unit No. 3, Operative Unit of Geriatrics, Acireale (CT): S. Branca
Local Sanitary Unit No. 6, Azienda Ospedaliera dei
Bianchi, Corleone (PA): G. Fradà.
Physiotherapist: F. Motta
Laboratory technician: G. Crimi

All the listed participants of this study have contributed to the identification of cases, elaboration and compilation of the clinical records, to collection and evaluation of the data, therefore, the present work is the result of an intense collegial activity. We declare that all participants of IMUSCE have equal merits in all parts of this work.

References

Alexandersen P, de Terlizzi F, Tankò LB, Bagger YZ, Christiansen C. Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women. Osteoporos Int. 2005;16:1071–1078. [PubMed]
Allain TJ, Dhesi J. Hypovitaminosis D in older adults. Gerontology. 2003;49:273–278. [PubMed]
Baggio G, Donazzan S, Monti D, Mari D, Martini S, Gabelli C, Dalla Vestra M, Previato L, Guido M, Pigozzo S, Cortella I, Crepaldi G, Franceschi C. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J. 1998;12:433–437. [PubMed]
Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med. 1997;157:629–634. [PubMed]
Bollen AM, Kiyak HA, Eyre DR. Longitudinal evaluation of a bone resorption marker in elderly subjects. Osteoporos Int. 1997;7:544–549. [PubMed]
Boonen S, Aerssens J, Dequeker J. Age-related endocrine deficiencies and fractures of the proximal femur. Implications of vitamin D deficiency in the elderly. J Endocrinol. 1996;149:13–17. [PubMed]
Boonen S, Bischoff-Ferrari HA, Cooper C, Lips P, Ljunggren O, Meunier PJ, Reginster JY. Addressing the musculoskeletal component of fracture risk with calcium and vitamin D: a review of the evident. Calcif Tissue Int. 2006;78:257–270. [PubMed]
Bringhurst FR. Calcium and phosphate distribution, turnover and metabolic actions. In: DeGroot LJ, editor. Endocrinology. third. Saunders; Philadelphia: 1995. pp. 1015–1043.
Burckhardt P. Calcium and vitamin D in osteoporosis: supplementation or treatment? Calcif Tissue Int. 2002;70:74–77. [PubMed]
Carrington JL. Aging bone and cartilage: cross-cutting issues. Biochem Biophys Res Commun. 2005;328:700–708. [PubMed]
Chapuy MC, Arlot M, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fracture in elderly women. N Engl J Med. 1992;327:1637–1642. [PubMed]
Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalent of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7:439–443. [PubMed]
Chapuy MC, Durr F, Chapuy P. Age-related-changes in parathyroid-hormone and 25 hydroxicholecalciferol levels. J Gerontol. 1983;38:19–22. [PubMed]
Chen C, Noland KA, Kalu DN. Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and growth hormone. Mech Ageing Dev. 1997;99:109–1222. [PubMed]
Clemens TL, Zhou XY, Myles M, Endres D, Lindsay R. Serun vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab. 1986;63:656–660. [PubMed]
Cooper C, Champion G, Melton LJ. Hip fractures in the elderly: a worldwide projection. Osteoporos Int. 1992;2:285–289. [PubMed]
De Benedictis G, Falcone E, Rose G, Ruffolo R, Spadafora P, Baggio G, Bertolini S, Mari D, Mattace R, Monti D, Morellini M, Sansoni P, Francesxhi C. DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus Hum Genet. 1997;99:312–318.
Deiana L, Ferrucci L, Pes GM, Carru C, Delitala G, Ganau A, Mariotti S, Nieddu A, Pettinato S, Putzu P, Franceschi C, Baggio G. AKEntAnnos. The Sardinia study of extreme longevity. Aging (Milano) 1999;11:142–149. [PubMed]
Duque G, Abdaimi K, Macoritto M, Miller MM, Kremer R. Estrogen (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 in bone cells: changing with aging and hormone deprivation. Biochem Biophys Res Commun. 2002;299:446–454. [PubMed]
Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics and biological markers. J Clin Endocr Metab. 1988;67:741–748. [PubMed]
Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res. 1991;6:125–132. [PubMed]
Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25.dihydroxyvitamin D and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab. 1992;75:176–182. [PubMed]
Elkeles A. A comparative radilogical study of calcified atheromas in males and females over 50 years of age. Lancet. 1957;11:714–715. [PubMed]
Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES, Nevitt MC, Fox KM, Cummings SR. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res. 1995;10:1778–1787. [PubMed]
Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P. Shortage of circulating naive CD8 T cells provides new insights on immunodeficiency in aging. Blood. 2000;95:2860–2868. [PubMed]
Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189–198. [PubMed]
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Magnesium, Phosphorus, Vitamin D, and Fluroide. National Academy Press; Washington, DC: 1997.
Forero MS, Klein RF, Nissenson RA, Nelson K, Heath H, 3rd, Arnaud CD, Riggs BL. Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women. J Bone Miner Res. 1987;2:363–366. [PubMed]
Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individual: the lesson of centenarians. Immunol Today. 1995;16:12–16. [PubMed]
Fujita T. Aging and calcium. Mineral Electrolyte Metab. 1986;12:149–156.
Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res. 1996;11:1531–1538. [PubMed]
Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to 1,25(OH)2D3 in oophorectomized women. J Clin Endocrinol Metab. 1990;71:1288–1293. [PubMed]
Glerup H, Milkkelsen K, Poulsen LH, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P, Eriksen EF. Commonly recommended daily intake of Vitamin D is not sufficient if sunlight exposure is limited. J Intern Med. 2000;247:260–268. [PubMed]
Glüer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: Expert agreement on current status. J Bone Miner Res. 1997;12:1280–1288. [PubMed]
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Med Sci. 1994;49:M85–M94.
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznik SH, Dominguez CE, Jurutka PW. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325–349. [PubMed]
Heaney RP, Dowel MS, Hale CA. Calcium absorption varies within the reference range for serum 25-hydroxivitamin D. J Am Coll Nutr. 2003;22:142–146. [PubMed]
Heaney RP. Editorial: vitamin D, nutritional deficiency, and the medical paradigm. J Clin Endocrinol Metab. 2003;88:5107–5108. [PubMed]
Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr. 2004;80(Suppl 1):1706S–1709S. [PubMed]
Hofbauer LC, Schopper M. Clinical implications of osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004;292:490–495. [PubMed]
Holick MF. McCollum award lecture. Vitamin D: new horizons for the 21st century. Am J Clin Nutr. 1994;60:619–630. [PubMed]
Holick MF. Vitamin D: photobiology metabolism and clinical applications. In: DeGroot L, Besser H, Burger HG, editors. Endocrinology. third. WB Saunders; Philadelphia: 1995. pp. 990–1013.
Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int. 2003;14:577–582. [PubMed]
Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–199. [PubMed]
Johnell O, Kanis JA. An estimate of worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726–1733. [PubMed]
Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G. The osteoprotegerin/RANK/RANKL system: a bone key to vascular diseases. Expert Rev Cardiovasc Ther. 2006;4:801–811. [PubMed]
Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ. Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25-dihydroxyvitamin D in normal young and elderly women. J Bone Miner Res. 1997;12:922–928. [PubMed]
Khosla S, Arrighi HM, Melton LJ, III, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL. Correlates of osteoportegerin levels in women and men. Osteoporos Int. 2002;13:394–399. [PubMed]
Krieg MA, Cornuz J, Ruffieux C, Van Melle G, Buche D, Dambacher MA, Hans D, Hartl F, Hauselmann HJ, Kraenzlin M, Lippuner K, Neff M, Pancaldi P, Rizzoli R, Tanzi F, Theiler R, Tyndall A, Wimpfheimer C, Burckhardt P. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res. 2006;21:1457–1463. [PubMed]
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T. Osteoprotegerin (OPG) is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–176. [PubMed]
Lorè F, Di Cairano G, Di Perri G. Vitamin D status in the extreme age of life. Ann Med Interne. 1986;137:209–211.
Lund B, Sorensen OH, Lund B, Agner E. Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy. Horm Metab Res. 1982;14:271–274. [PubMed]
Lund J, DeLuca H. Biologically active metabolite of vitamin D3 from bone, liver and blood serum. J Lipid Res. 1969;7:739–744. [PubMed]
Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone action in normal humans. J Clin Endocr Metab. 1984;58:223–230. [PubMed]
Marcus R, Feldman D, Kelsey J. Osteoporosis. Academic Press; New York: 1995.
Mari D, Mannucci PM, Duca F, Bertolini S, Franceschi C. Mutant factor V (Arg506Gln) in healthy centenarians. Lancet. 1996;347:22–26.
Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, Giacomelli T, Passeri G, Fagiolo U, Pinchera A, Franceschi C. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 1992;339:1506–1508. [PubMed]
Martini S, Passeri G. Il metabolismo del calcio e della vitamina D. In: Bianchi G, Girasole G, editors. Malattie metaboliche dello scheletro dell'an-ziano. Hydros S.r.L. Publisher; Parma, Italy: 2000. pp. 25–39. Italian.
Mazziotti G, Amato G, Sorvillo F, Piscopo M, Rizzo MR, Lalli E, Iride L, Ciuffi M, Molinari AM, Paolisso G, Carella C. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism. Eur J Endocrinol. 2006;154:373–377. [PubMed]
McKane WR, Khosla S, Eagan KS, Robins SP, Burritt MF, Riggs BL. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab. 1996;81:1699–1703. [PubMed]
Nieves JW. Calcium, vitamin D and nutrition in the elderly. Clin Geriatr Med. 2003;19:321–335. [PubMed]
Nuti R, Martini G. The role of vitamin D and its metabolites in osteomalacia and involutional osteoporosis. Ital J Miner Electrolyte Metab. 1994;8:225–232.
Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM. Vitamin D status and sex hormone-binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res. 1995;10:1177–1184. [PubMed]
Orimo H, Ouchi Y. The role of calcium and magnesium in the development of atherosclerosis. Experimental and clinical evidence. Ann N Y Acad Sci. 1990;598:444–457. [PubMed]
Parfitt AM. Calcium homeostasis. In: Mundy GR, Martin TJ, editors. Physiology and Pharmacology of Bone Handbook of Experimental Pharmacology. Vol. 107. Springer; Philadelphia: 1993. pp. 1–65.
Passeri M. Le alterazioni senili dell'omeostasi del calcio e del fosforo. Giorn Geront. 1991;39:327–339. Italian.
Passeri G, Pini G, Troiano L, Vescovini R, Sansoni P, Passeri M, Gueresi P, Delsignore R, Pedrazzoni M, Franceschi C. Low vitamin D status, high bone turnover and bone fractures in centenarians. J Clin Endocrin Metab. 2003;88:5109–5115.
Passeri G, Galli C, Telera AR, Vescovini R, Macaluso GM, Minelli R, Delsignore R, Sansoni P, Pedrazzoni M. Osteoprotegerin and RANK-L in extreme longevity, and their changes during the aging process. J Bone Miner Res. 2005;(suppl 1):s190. abs.
Pulsatelli L, Dolzani P, Silvestri T, Caraceni P, Facchini A, Ravaglia G, Salvarani C, Meliconi R, Mariani E. Soluble receptor activator of nuclear factor-kB (sRANK-L)/osteoprotegerin balance in ageing and age associated diseases. Biogerontology. 2004;5:119–127. [PubMed]
Raisz SZ. Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest. 2005;115:3318–3325. [PMC free article] [PubMed]
Ringe JD. Vitamin D deficiency and osteopathies. Osteoporos Int. 1998;S8:35–39.
Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr. 1999;81:133–137. [PubMed]
Rosen CJ, Kiel DP. The aging skeleton. In: ASBMR, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th. Lippincott Williams and Wilkins; Philadelphia: 1999. pp. 57–59.
Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 1998;13:297–303. [PubMed]
Rossini M, Perbellini S, Lazarin M, Adami S, Bertoldo F, Lo Cascio V. Incidenza di ipovitaminosi D nel Nord Italia. Ital J Miner Electrolyte Metab. 1990;4:13–17. Italian.
Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seibel MJ. High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res. 2006;21:549–555. [PubMed]
Sambrook PN, Cooper C. Osteoporosis. Lancet. 2006;367:2010–2018. [PubMed]
Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E, Fagiolo U, Passeri M, Franceschi C. Lymphocyte subsets and natural killer cell activity in healthy old-people and centenarians. Blood. 1993;82:2767–2773. [PubMed]
Schett G, Kiechel S, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu Q, Pietshmann P, Teitelbaum S, Smolen J, Willet J. Soluble RANKL abd risk of nontraumatic fracture. JAMA. 2004;291:1108–1113. [PubMed]
Sheikh MS, Ramirez A, Emmett M, Santa Ana C, Schiller LR, Fordtran JS. Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium. J Clin Invest. 1988;81:126–132. [PMC free article] [PubMed]
Suda T, Takahashi N, Abe E. Role of vitamin D in bone resorption. J Cell Biochem. 1992;49:53–58. [PubMed]
Suda T, Ueno K, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem. 2003;88:2259–2266.
Suki WN, Rouse D. Renal transport of calcium, magnesium and phosphate. In: Brenner BM, editor. The Kidney. WB Saunders; Philadelphia: 1996. pp. 472–515.
Tsai KS, Heath H, III, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest. 1984;73:1668–1672. [PMC free article] [PubMed]
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D₃ (cholecalciferol) supplementation on fractures and mortality in men and women living in community: randomized double blind controlled trial. Br Med J. 2003;326:469–474. [PMC free article] [PubMed]
Wilkins CH, Birged SJ. Prevention of osteoporotic fractures in the elderly. Am J Med. 2005;118:1190–1995. [PubMed]
Wüster C, Albanese C, De Aloysio D, Duboeuf F, Gambacciani M, Gonnelli S, Gluer CC, Hans D, Joly J, Reginster JY, De Terlizzi F, Cadossi R. Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res. 2000;15:1603–1614. [PubMed]
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SL, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998;95:3597–3602. [PMC free article] [PubMed]

Formats:

PubMed articles by these authors

PubMed related articles

Recent Activity

Links

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information